Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001951291 | SCV002241908 | pathogenic | not provided | 2021-08-02 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Gln260*) in the SMARCB1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SMARCB1 are known to be pathogenic (PMID: 10521299, 21208904). This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals affected with SMARCB1-related conditions. This variant is also known as INI1 c.778C>T. For these reasons, this variant has been classified as Pathogenic. |